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Burkholderia is a genus within the β-Proteobacteriaceae that contains at least 90 validly
named species which can be found in a diverse range of environments. A number of
pathogenic species occur within the genus. These include Burkholderia cenocepacia
and Burkholderia multivorans, opportunistic pathogens that can infect the lungs of
patients with cystic fibrosis, and are members of the Burkholderia cepacia complex
(Bcc). Burkholderia pseudomallei is also an opportunistic pathogen, but in contrast to
Bcc species it causes the tropical human disease melioidosis, while its close relative
Burkholderia mallei is the causative agent of glanders in horses. For these pathogens to
survive within a host and cause disease they must be able to acquire iron. This chemical
element is essential for nearly all living organisms due to its important role in many
enzymes and metabolic processes. In the mammalian host, the amount of accessible
free iron is negligible due to the low solubility of the metal ion in its higher oxidation state
and the tight binding of this element by host proteins such as ferritin and lactoferrin.
As with other pathogenic bacteria, Burkholderia species have evolved an array of iron
acquisition mechanisms with which to capture iron from the host environment. These
mechanisms include the production and utilization of siderophores and the possession
of a haem uptake system. Here, we summarize the knownmechanisms of iron acquisition
in pathogenic Burkholderia species and discuss the evidence for their importance in the
context of virulence and the establishment of infection in the host. We have also carried
out an extensive bioinformatic analysis to identify which siderophores are produced by
each Burkholderia species that is pathogenic to humans.
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THE ROLE OF IRON IN BACTERIA AND SOURCES OF IRON
WITHIN THE HOST
Iron mainly occurs in either of two oxidation states in biological systems, Fe2+ and Fe3+ (also
referred to as Fe(II) and Fe(III) or ferrous and ferric, respectively), the latter being the oxidized
form that also prevails in the earth’s crust, whereas the former is favored by low pH and low oxygen
concentrations (Sanchez et al., 2017). It is the ability of iron to be interconverted between these two
states that is the basis of many redox reactions that occur in cells (Andrews et al., 2003). For almost
all species of bacteria, iron is essential as it is an important component of many proteins. It may
occur as part of the haem cofactor, as in cytochromes and haem-type catalases, or as an iron-sulfur
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center, as in ferredoxins, rubredoxins, nitrogenase, sulfite
reductase, and other iron-sulfur proteins, or as mono- or
dinuclear non-haem iron that occurs in Fe-dependent superoxide
dismutase and in class Ia ribonucleotide reductases, respectively
(Caza and Kronstad, 2013). However, despite the relatively high
iron content within humans and animals, it is not freely available
due to sequestration by proteins that include hemoglobin,
transferrin, lactoferrin, and ferritin, and the fact that it is largely
present in the intracellular compartment (Skaar, 2010). This
presents a problem to pathogenic microbes that demands the
possession of high affinity iron capturing systems if they are to
cope with the otherwise bacteriostatic environment. The reader
is referred to the following reviews for a more comprehensive
discussion of this subject (Nairz et al., 2010; Skaar, 2010; Parrow
et al., 2013; Runyen-Janecky, 2013).
THE GENUS BURKHOLDERIA
Burkholderia is a genus within the β-Proteobacteriaceae that
contains at least 90 validly named species but will almost certainly
include many more (Depoorter et al., 2016). Members of the
genus are diverse and may be found as free-living species within
soil or water, or in association with other hosts, including
plants, fungi, animals and humans (Smith et al., 1995; Parke
and Gurian-Sherman, 2001). They contain large genomes in the
range of 7–9Mb that are typically organized into two or three
chromosomes. Based on 16S rRNA sequences, two major clades
account for almost all of the currently described species (the
endosymbionts B. rhizoxinica and B. endofungorum being the
two exceptions; Figure 1). One clade consists of a large group
of environmental and plant-associated species referred to as
the Burkholderia xenovorans group, together with the deeper
branching species B. caryophylli, B. soli, and B. symbiotica. The
other clade consists of two large groups [the B. glathei group
and the B. cepacia complex (or Bcc)] and two smaller groups
(the Burkholderia pseudomallei group and a plant pathogenic
group consisting of Burkholderia gladioli, B. glumae, and B.
plantarii) (Depoorter et al., 2016). More recently, most of the
non-pathogenic species (i.e., the B. xenovorans and B. glathei
groups along with B. caryophylli, B. soli, and B. symbiotica) have
been transferred to the new genus Paraburkholderia (Sawana
et al., 2014; Oren and Garrity, 2015) and subsequently the B.
glathei group has been transferred to the new genus Caballeronia
(Dobritsa and Samadpour, 2016; Figure 1), although it is not
clear whether the new classification schemes will be accepted
by the scientific community (Depoorter et al., 2016). For the
purposes of this review we will refer to all species as belonging
to the genus Burkholderia (whichever classification scheme is
adopted, the pathogenic species will remain within the genus
Burkholderia). Of the pathogenic species, members of the Bcc
and B. pseudomallei group can cause life-threatening infections
in humans, and this feature will be discussed in this review
in the context of their iron acquisition mechanisms. The
phytopathogen B. gladioli also causes opportunistic infections in
humans, but as little is known concerning its iron acquisition
mechanisms it will not be discussed in detail.
BCC INFECTIONS AND CYSTIC FIBROSIS
The Bcc constitute a group of at least 20 closely related species
within the genus (Table 1). Members of the Bcc are well-known
for causing infections in the lungs of cystic fibrosis (CF) patients,
although they are also associated with infections of patients
with chronic granulomatous disease and in individuals who are
compromised for other reasons (Song et al., 2011). Although
almost all Bcc species have been recovered from CF patient
sputum, the most prevalent species are B. cenocepacia and
B. multivorans, and consequently they have been the subject
of most studies on potential virulence mechanisms (Reik et al.,
2005; Drevinek and Mahenthiralingam, 2010; Zlosnik et al.,
2015). Infections with Bcc have variable outcomes and may
include transient or chronic asymptomatic infections, or they
may cause a rapid decline in lung function which in some cases
is accompanied by bacteraemia leading to death of the patient
(“Cepacia syndrome;” Isles et al., 1984; Mahenthiralingam et al.,
2001; Courtney et al., 2004; Jones et al., 2004). Infections with
Bcc species are extremely difficult to eradicate due to their high
level of intrinsic resistance tomany antibiotics and biocides (Rose
et al., 2009; Rhodes and Schweizer, 2016) [Note: prior to 2005,
bacteria described as B. cepacia (and as Pseudomonas cepacia
prior to the proposal of the genus Burkholderia in 1992) largely
included members of related species within the Bcc that were not
recognized as such at the time (Yabuuchi et al., 1992; Lipuma,
2005). This needs to be borne in mind when considering the
results from some of the earlier investigations described below,
particularly those in which a large number of “P. cepacia” or “B.
cepacia” isolates were analyzed].
Cystic fibrosis (CF) is the most common autosomal recessive
disorder among Caucasians. It is caused by mutations to the gene
encoding the CF transmembrane conductor regulator (CFTR),
which primarily functions as a gated chloride ion transporter but
also regulates other apical membrane ion transporters (Davies
et al., 2007). This defect leads to a more viscous lung mucus
that impairs the action of the mucociliary escalator (Matsui
et al., 1998, 2005; Boucher, 2007). Moreover, the high viscosity
of the mucosal secretions may hinder the access of secreted
cationic antimicrobial peptides from submucosal glands to the
epithelial surface and may also restrict migration of neutrophils
(see Doring et al., 2011; Tang et al., 2014 for reviews). Additional
effects of a defective CFTR are also likely to be at play in
facilitating pathogen survival in the airway surface liquid (ASL)
of the CF lung (reviewed in Doring and Gulbins, 2009; Tang
et al., 2014; Elborn, 2016), including increased abundance of
amino acids (Barth and Pitt, 1996; Thomas et al., 2000), lowered
pH (Song et al., 2006; Yoon et al., 2006), increased neutrophil-
mediated oxidative stress (Kolpen et al., 2010), inflammation
(Perez et al., 2007), hypoxic regions (Worlitzsch et al., 2002), and
an altered iron status (see below). These phenomena conspire
to make CF patients particularly susceptible to infection from a
variety of bacterial, viral and fungal pathogens (Harrison, 2007).
Despite extensive research, the key virulence determinants
of Bcc members that lead to establishment of an infection,
persistence and morbidity in CF patients still remain to be
established. Potential virulence determinants associated with the
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TABLE 1 | Siderophore biosynthesis in human pathogenic members of the genus Burkholderiaa.
Species Ornibactinb Malleobactinc Cepaciachelind Pyocheline Cepabactinf
BCCg
B. ambifaria + – +h – ?
B. metallica + – + – ?
B. multivorans + – +i – ?
B. pseudomultivorans + – +j – ?
B. pyrrocinia + – + – ?
B. stagnalis + – + – ?
B. ubonensis + – + – ?
Bcc ATCC 31433k + – + – ?
B. anthina + – – + ?
B. cenocepacia + – – + –
B. cepacia + – –l +m +
B. lata + – – + ?
B. paludis –n – – + ?
B. seminalis + – – + ?
B. stabiliso + – – + ?
B. arborisp ? ? – ? ?
B. contaminans + – – – ?
B. diffusa + – – – ?
B. dolosa + – – – ?
B. latens + – – – ?
B. territorii + – – –q ?
B. vietnamiensis + – – –r –
PSEUDOMALLEI GROUP
B. pseudomallei – + – + ?
B. mallei – + – – ?
OTHERS
B. gladioli – – – – ?
aThe potential of the listed species to produce each siderophore was deduced from a bioinformatic analysis of genome sequences using genes known to encode the biosynthesis of
each siderophore as a search query (except for cepabactin where the biosynthetic genes remain to be identified). In some cases, the production (or not) of a siderophore by a specific
strain has been demonstrated (see below and main text for details).
bOrnibactin production has been confirmed in B. ambifaria, B. cenocepacia, B. cepacia, and B. vietnamiensis (Stephan et al., 1993; Meyer et al., 1995; Barelmann et al., 1996; Darling
et al., 1998; Agnoli et al., 2006).
cPresumed to be malleobactin E for B. pseudomallei and B. mallei based on the known structure of the B. thailandensis siderophore (Franke et al., 2015).
dCepaciachelin production has only been confirmed in B. ambifaria (Meyer et al., 1989).
eB. cenocepacia, B. cepacia, B. paludis, and B. pseudomallei have been demonstrated to produce pyochelin whereas B. vietnamiensis isolates do not (Meyer et al., 1995; Darling et al.,
1998; Alice et al., 2006; Kvitko et al., 2012; Ong et al., 2016).
fCepabactin has been identified in culture supernatants from two B. cepacia environmental strains (ATCC 25416 and ATCC17759) but not in environmental or clinical isolates of
B. vietnamiensis [including the type strain TVV75 (LMG 10929)] (Meyer et al., 1989, 1995). It was not detected in culture supernatants of B. cenocepacia clinical isolates K56-2 and
715j (Darling et al., 1998).
gMember species of the Bcc are as listed in Depoorter et al. (2016) with the addition of B. paludis (Ong et al., 2016) and a potential new member Bcc ATCC 31433 (Loveridge et al.,
2017).
hB. ambifaria PHP7 (LMG 11351) and the type strain AMMD (LMG 19182) have been shown to produce cepaciachelin, whereas strains MC40-6, MEX-5 and IOP40-10 do not possess
the required genes (this study; Barelmann et al., 1996; Esmaeel et al., 2016).
iAlthough, several B. multivorans strains encode the capacity to produce cepaciachelin, some (including ATCC 17616 and the type strain LMG 13010) do not (this study; Esmaeel et al.,
2016).
jCepaciachelin gene cluster is present in B. pseudomultivorans strain MSMB368 but not in other strains currently in the database.
kBcc ATCC 31433 is closely related to B. ubonensis, but possibly constitutes a separate species (Loveridge et al., 2017).
lB. cepacia LK29 has the genetic capacity to produce cepaciachelin but other B. cepacia strains for which genome sequences are available do not (this study; Esmaeel et al., 2016).
mB. cepacia ATCC 25416 (the type strain) and ATCC 17759 produce pyochelin whereas strain GG4 does not encode the capacity to produce this siderophore (Meyer et al., 1995;
Deng et al., 2016; Esmaeel et al., 2016).
nB. paludis encodes the ferric ornibactin transport system but not the biosynthetic apparatus. The fact that it retains OrbE may suggest recycling of the siderophore.
oAt the time of writing, three B. stabilis complete genome sequences had been deposited in the database. The type strain (ATCC BAA-67) and FERMP-21014 contain the pyochelin
biosynthesis and utilization genes on chromosome 2, whereas strain LA20W lacks these genes and carries the cepaciachelin gene cluster.
pSiderophore status is unknown due to unavailability of genome sequence information.
qB. territorii A63 contains the pyochelin gene cluster. Other strains, including the type strain, do not have it.
rPyochelin was not detected in culture supernatants of clinical and environmental isolates of B. vietnamiensis (Meyer et al., 1995).
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FIGURE 1 | The major groups of Burkholderia species. Groups are based on the 16S rRNA-based phylogenetic tree (see, for example, Depoorter et al., 2016).
Species most commonly associated with infections in humans are shown in red font (for a full list of the Bcc species see Table 1). Alternative classification schemes
involving the proposed new genera Paraburkholderia and Caballeronia are also indicated (see text for details). Recently, it has been proposed that B. rhizoxinica
should be transferred to a new, as yet unnamed genus (Beukes et al., 2017).
Bcc, including their ability to survive intracellularly (including
within macrophages) (Lamothe and Valvano, 2008; Vergunst
et al., 2010; Valvano, 2015; Mesureur et al., 2017), have
been the subject of several comprehensive reviews and are
not discussed here (Drevinek and Mahenthiralingam, 2010;
Loutet and Valvano, 2010; Sousa et al., 2011). One of the
problems in identifying the pathogenic mechanisms is that there
are few candidate virulence determinants that are associated
with all member species of the Bcc, and indeed even among
different strains within the same species some these determinants
may not be conserved. However, one trait that does appear
to be required for virulence in Bcc species is the ability
to acquire iron from iron depleted environments such as
within the human host. A large number of studies have been
carried out on the virulence strategies of the most commonly
isolated bacterial pathogen from CF patients, P. aeruginosa,
particularly in relation to its ability to colonize the CF lung
and the role that iron acquisition mechanisms may play in
this process. This knowledge may inform our understanding
of the conditions prevailing within the CF lung and the iron
acquisition mechanisms that are important for establishment
of an infection by Bcc species. Where relevant, pertinent data
obtained from studies on P. aeruginosa will be discussed in this
review.
THE ROLE OF IRON ACQUISITION
MECHANISMS IN BCC INFECTIONS
Iron Availability in the CF Lung
In considering the potential role of iron acquisition systems in the
CF lung it is worth reviewing what we know considering the iron
content of CF sputum and its bioavailability. Based on the known
iron limiting environment of the ASL of the healthy lung, where
iron is sequestered by lactoferrin, transferrin, and ferritin, it was
long assumed that the CF lung also generated an iron-deficient
environment (Drevinek et al., 2008). Indeed, the results of some
investigations into the regulation of iron acquisition genes in the
major CF pathogen, Pseudomonas aeruginosa, appeared to lend
support to this contention (see below). However, measurements
of the iron content of the CF lung have led to a reappraisal of this
environment. It is now clear that the lungs of CF patients have, on
average, a higher iron content than that of a healthy individual.
For example, it was shown that the abundance of the iron storage
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protein, ferritin, was on average nearly 20-fold higher in the lungs
of CF patients compared to healthy individuals, while there was
∼50% less transferrin (Stites et al., 1998). Other investigators
have confirmed the high ferritin concentrations in CF sputum
(Reid et al., 2002, 2004). In a more recent investigation, the
total iron content and the fractions that were in the Fe(II)
and Fe(III) forms were measured in CF patients experiencing
differing degrees of disease severity (Hunter et al., 2013). This
showed a strong positive correlation between the iron content
of CF sputum and the progression of the disease. Thus, patients
with severe disease (as judged by their low FEV) had a high mean
iron concentration in their sputum of 72µM compared to those
with a milder condition where the mean was 18µM. Moreover,
a substantial fraction of iron was present in the soluble ferrous
form which increased in line with disease severity, such that in
the most severe disease stage, ferrous iron constituted ∼40% of
the total iron load (Hunter et al., 2013). The increased abundance
of Fe(II) in severe or late-stage CF disease is likely to be due
to the reduction of Fe(III) by neutrophil-generated superoxides
and stabilization of the resultant ferrous form by the increased
prevalence of hypoxic zones in parts of the lung and acidification
of the ASL.
Another source of iron that is more abundant in the CF
lung is haem. This molecule becomes available through its
release from hemoglobin which can occur following oxidation
of the coordinated ferrous iron atom or following proteolysis
of hemoglobin by host- or pathogen-derived proteases (Balla
et al., 1993; Cosgrove et al., 2011). Lung tissue may release
iron, including sources of haem, through injury due to the
ravages of chronic inflammation (Reid et al., 2004). Moreover, CF
patients experience a high frequency ofmicro-bleeds in their lung
tissue that results in hemoglobin entering their ASL (Cosgrove
et al., 2011). The frequency of airway bleeding in CF patients
increases during pulmonary exacerbations where symptoms
become more severe (Reid et al., 2009). The availability of ferrous
iron and haem, particularly in the later stages of the disease,
has potential implications for the iron acquisition systems that
may be deployed by a colonizing pathogen. This change in
our understanding of the iron status of the CF lung has led
some workers to propose that the CF lung environment actually
facilitates the growth of organisms such as P. aeruginosa (Reid
et al., 2007).
Iron Acquisition Mechanisms of the Bcc
Many bacteria synthesize and secrete low molecular weight,
high affinity iron chelating compounds known as siderophores
which they employ to capture iron from their local environment,
particularly when this element is scarce (Chu et al., 2010). Due to
its propensity to form poorly soluble hydroxides in solution, such
as Fe(OH)+2 , an important role of the siderophore is to solubilize
the ferric form of iron (Chipperfield and Ratledge, 2000; Ratledge
and Dover, 2000). The affinities of some siderophores for iron
are sufficiently high to allow them to obtain iron from host
iron transport proteins such as lactoferrin and transferrin, but
not from haem (Skaar, 2010). These compounds contain one,
two, or three bidentate ligands that allow them to coordinate
to a single Fe(III) ion, the predominant form of iron in aerobic
environments at physiological pH. As iron forms hexavalent
coordination complexes with its ligands, a single siderophore
molecule containing three bidentate ligands (i.e., a hexadentate
siderophore) will form a 1:1 complex with one ferric ion giving
rise to an overall octahedral geometry (Neilands, 1995; Ratledge
and Dover, 2000). Under iron replete conditions, synthesis
of these molecules (and expression of other iron acquisition
systems) is, in most cases, strongly downregulated in order to
prevent cytoplasmic iron overload that may generate high levels
of toxic reactive oxygen intermediates via the Fenton reaction
(for reviews see Andrews et al., 2003; Cornelis et al., 2011).
Members of the Bcc have been shown to produce one or
more of four different siderophores with which they can acquire
iron: ornibactin, cepaciachelin, pyochelin, and cepabactin
(Meyer et al., 1989, 1995; Stephan et al., 1993; Barelmann
et al., 1996; Darling et al., 1998). These siderophores include
all three types (bidentate, tetradentate, and hexadentate) and
all of the most common iron binding ligands are represented
among them (hydroxamate, hydroxycarboxylate, catechol,
and 2-hydroxyphenylthiazoline; Figure 2). The biosynthesis of
pyochelin and ornibactin and the genetic regulation of their
synthesis have been reviewed elsewhere, while the biosynthetic
genes for cepaciachelin have been recently identified (Thomas,
2007; Esmaeel et al., 2016). For this review, we have surveyed
the distribution of ornibactin, cepaciachelin, and pyochelin
among the Bcc by carrying out a bioinformatic analysis of
the genomes of 21 Bcc members using the corresponding
biosynthetic genes as search queries (Table 1). The results
accord with more limited surveys carried out previously (Deng
et al., 2016; Esmaeel et al., 2016). We have also augmented
the bioinformatics analysis by referencing those cases where
production of a particular siderophore by specific Bcc species has
actually been demonstrated. Currently, this is the only way of
ascertaining which species specify cepabactin, as the biosynthetic
genes remain to be identified.
Based on bioinformatic analysis of genome sequences, all Bcc
species (apart from the recently described Burkholderia paludis)
are predicted to produce the siderophore ornibactin, which is
likely to act as the primary secreted iron chelator in these
organisms based on its hexadenticity (Table 1 and Figure 3).
Although ornibactin and malleobactin E (the siderophore
produced by members of the B. pseudomallei group) are very
similar (Figure 2), and therefore require similar biosynthetic
enzymes for their assembly (Figure 3), a key feature that
distinguishes the type of siderophore produced by each species
is the presence of a distinct amino acid activation (adenylation)
domain at the N-terminus of the larger of the two non-ribosomal
peptide synthetases (NRPSs) that assemble these tetrapeptide
siderophores (OrbI in the case of ornibactin). This domain
activates the derivatized ornithine that will be located at the
N-terminus of the tetrapeptide (for further details the reader
is referred to Thomas, 2007 and the legend to Figure 3). In
addition, as the δ-amino group of the N-terminal ornithine
residue of ornibactin is acylated with a β-hydroxycarboxylic acid
(rather than formic acid as in malleobactin E), the ornibactin
gene cluster is distinguished by the presence of at least one of two
genes (orbK and orbL) that are predicted to encode an acylase that
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FIGURE 2 | Structure of siderophores produced by Burkholderia species. (A) Ornibactins contain an N-terminal ornithine that is acylated with a C4, C6, or C8
β-hydroxycarboxylic acid on the δ-amino nitrogen atom, giving rise to ornibactin-C4, -C6, or -C8. The δ-amino nitrogen atom is also hydroxylated. The other three
amino acids in the tetrapeptide are D-hydroxyaspartate, L-serine and the C-terminal ornithine that is formylated and hydroxylated on the δ-amino nitrogen atom and
the carboxyl group is conjugated to putrescine. As with the malleobactins, they contain two bidentate β-hydroxycarboxylate ligands and a single bidentate
hydroxamate ligand. (B) Malleobactin E, the siderophore-active malleobactin congener of B. thailandensis. (C) The siderophore-active malleobactin congener of B.
xenovorans, tentatively referred to here as “malleobactin X.” (D) Cepaciachelin contains two 2,3-DHBA groups that form amide linkages with the two amino groups of
lysine, which in turn is conjugated to a molecule of putrescine (1,4-diaminobutane) on its α-carboxyl group. (E) Pyochelin contains two less commonly occurring
bidentate iron-chelating groups (2-hydroxyphenyl thiazoline and N-methylthiazolidine-4-carboxylate). (F) Cepabactin, a cyclic hydroxamate bidentate siderophore.
Chemical groups that distinguish the ornibactins and malleobactins are indicated in red circles or ellipses.
catalyses this condensation reaction (Figure 3). Whereas orbL
is always present, orbK may contain an internal deletion (as in
B. ubonensis) or be absent from the cluster altogether (as in B.
vietnamiensis). Although, the single reported B. paludis strain
is an environmental isolate, it should be noted that in a survey
of “B. cepacia” CF isolates carried out prior to the taxonomic
reorganization of B. cepacia into separate Bcc species, two clinical
strains were found not to produce detectable levels of ornibactin
(Darling et al., 1998). It is not clear to which Bcc member species
they belong or whether they are indeed members of the Bcc.
One possibility is that these strains were capable of producing
ornibactin prior to infection but this ability was lost through
mutation during prolonged carriage as has been observed with
respect to production of the major siderophore pyoverdine by
some P. aeruginosa strains isolated from chronically infected CF
patients (De Vos et al., 2001; Smith et al., 2006; Andersen et al.,
2015).
In addition, most Bcc species produce one or more secondary
siderophores that are likely to have lower affinity for iron
than ornibactin. The gene clusters specifying the biosynthesis
and utilization of two of these siderophores, cepaciachelin
and pyochelin, are shown in Figures 4A,B. Based on our
bioinformatics survey, at least 7 species of Bcc, including B.
cenocepacia and B. lata, produce pyochelin as the secondary
siderophore, a feature associated with some Pseudomonas species
(Cornelis and Matthijs, 2002), whereas in 8 other species,
including some strains of B. ambifaria and B. multivorans, the
secondary siderophore is cepaciachelin (Table 1). We have not
identified a species possessing the genetic information required
to produce both cepaciachelin and pyochelin. Both compounds
are tetradentate siderophores, although the former belongs to
the 2-hydroxyphenylthiazoline family whereas cepaciachelin is
a bis-catecholate siderophore (Barelmann et al., 1996; Thomas,
2007; Inahashi et al., 2017). Some species do not appear
to produce either of these two compounds as a secondary
siderophore (Table 1). Another siderophore, the bidentate
cyclic hydroxamate, cepabactin, has been detected in culture
supernatants of some environmental B. cepacia strains in
addition to ornibactin and pyochelin (see Table 1; Meyer et al.,
1989, 1995). The ability of some clinical Bcc isolates of unknown
taxonomic status to produce cepabactin has also been observed
(Darling et al., 1998). Currently, it is not possible to infer from
bioinformatics how widespread the synthesis or utilization of this
siderophore is likely to be among the Bcc, although its production
has not been observed in B. cenocepacia and B. vietnamiensis
strains (Table 1).
The uptake of ferric-siderophore complexes by Gram-
negative bacteria such as the Burkholderia requires an outer
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FIGURE 3 | Organization of ornibactin, malleobactin, and phymabactin biosynthesis and utilization genes in pathogenic Burkholderia and related species. Genes are
represented by block arrows and are color coded as indicated in the figure [the precise role of the MbtH-like OrbH/MbaG/PhmF proteins is unknown but they are
assumed to be required for biosynthesis of the siderophore based on the requirement for other MbtH-like proteins for NRPS-mediated biosynthesis of some peptides;
(Wolpert et al., 2007; Baltz, 2011)]. The numbering of each gene cluster corresponds to the numbering system for the species listed at the bottom of the figure. The
font color used for each species name corresponds to the siderophore produced as follows: black, ornibactin; red, malleobactins; green, phymabactin.
NRPSpredictor2 (Rottig et al., 2011) was used to predict the siderophore product based on the substrates accepted by the four adenylation domains present in
OrbI/OrbJ, MbaA/MbaB, and PhmA/PhmB for each species. For systems known to specify ornibactin, the first and last (N- and C-terminal) adenylation domains of
the OrbI-OrbJ NRPS pair are both predicted to accept leucine with highest probability, reflecting the presence of N5-3-hydroxyacyl-N5-hydroxyornithine and
N5-formyl-N5-hydroxyornithine, respectively, at these positions in the tetrapeptide product. For malleobactin, the predicted specificity of the N-terminal adenylation
domain changes to β-hydroxytyrosine although the accepted substrate is N5-formyl-N5-hydroxyornithine. In some species, such as B. thailandensis, the N-terminal
N5-formyl-N5-hydroxyornithine is formylated on the N2-amino group upon formation of the tetrapeptide to generate malleobactin E (Franke et al., 2015), whereas in
B. xenovorans the N-terminal N5-formyl-N5-hydroxyornithine does not appear to undergo such a tailoring reaction (Vargas-Straube et al., 2016) and so we tentatively
refer to this siderophore as “malleobactin X.” The N- and C-terminal adenylation domains of PhmA-PhmB are predicted to accept aspartate and cysteine, respectively,
but the structure of the product, phymabactin, is unknown, although it is predicted to have siderophore activity based on its genomic context (Esmaeel et al., 2016). In
all cases, the second and third adenylation domains are predicted to accept aspartate and serine, respectively, which correspond to β-hydroxy-D-aspartate and
L-serine in the final product. The nomenclature proposed for each gene is shown below the gene clusters, and the gene designations are color coded as follows:
ornibactin, black (Agnoli et al., 2006); the two systems for malleobactin, red (upper, Alice et al., 2006; lower, Franke et al., 2013); the two systems for phymabactin,
green (upper, Esmaeel et al., 2016; lower, this study). Genes indicated by a single letter have the same prefix as the gene name at the extreme left. Dashes indicate
the absence of a gene. Question mark indicates where a gene name has not been proposed. The initial annotation of the phymabactin gene cluster (Esmaeel et al.,
2016) did not include the third and last genes in the cluster or the fact that a TBDR gene occurs in other species bearing this gene cluster (upper annotation in green
font). Therefore, we have proposed an alternative nomenclature based on the ornibactin gene cluster (lower annotation in green font). Scale bar refers to gene lengths
and not intergenic regions, which in some cases have been exaggerated to permit alignment of each gene cluster. Species marked with an asterisk belong to a
subclade within the B. xenovorans group and have been reassigned to the new genus Paraburkholderia (Sawana et al., 2014). Collimonas is a genus within the
Oxalobacteraceae, a family belonging to the order Burkholderiales. Member species of the Bcc are enclosed in a box (B. arboris is not listed as its genome sequence
is not currently available). Gene loci are shown in Supplementary Table 1.
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FIGURE 4 | Organization of the cepaciachelin and pyochelin biosynthesis and
utilization genes and the genes for the haem uptake system in Burkholderia
species. (A) The cepaciachelin gene cluster in Burkholderia species encodes
enzymes for the synthesis of the precursor 2,3-dihydroxybenzoic acid (DHBA)
from chorismate and its assembly into the siderophore. Genes encoding
possible cepaciachelin transport proteins are also present, including the
TonB-dependent receptor, CpcG, and an MFS transporter, CpcH. Most of the
genes have been previously annotated (Esmaeel et al., 2016) but the
annotation has been extended here (genes labeled in red font) and includes
components of a cytoplasmic membrane ABC transporter which may be
involved in uptake of ferric cepaciachelin (CpcF, -I, and -J). EstA is homologous
to the cytoplasmic enterobactin and salmochelin esterases Fes and IroD that
are required for removal of iron from ferric-enterobactins following their uptake.
However, it contains a putative Sec-dependent signal peptide and so may be
periplasmically located like the C. jejuni enterobactin esterase, Cee (Zeng et al.,
2013). This may suggest that the putative cepaciachelin receptor (CpcG) and
the cytoplasmic membrane transporter also recognizes ferric-enterobactin.
With the exception of B. ambifaria and B. pseudomultivorans the
cepaciachelin gene cluster includes a gene encoding a DAHP synthase which
catalyses the first step in the shikimate pathway that leads to the biosynthesis
of chorismate from erythrose-4-phosphate and PEP. Note that in Esmaeel
et al. (2016) cphA-cphC should be annotated as cpcA-cpcC, as shown here
(V. Leclere, personal communication). -, gene not assigned a four letter name.
Gene loci are shown in Supplementary Table 2. (B) The pyochelin gene cluster.
Genes annotated with a single letter are designated with the prefix pch.
Products of the biosynthetic genes generate the precursor salicylic acid from
chorismate (PchAB), activate it (PchD) and assemble it into pyochelin along
with two molecules of cysteine (PchCEFG). The pchHI and fptABCX genes
encode membrane proteins, of which two (FptA and FptX) are involved in the
transport of exogenous ferric-pyochelin across the outer and inner
membranes, respectively. fptBC and pchHI appear not to be essential for
export of pyochelin nor for uptake of iron-bound pyochelin (see Youard et al.,
2011 for a review). Gene loci are shown in Supplementary Table 3.
(C) Organization of the Burkholderia haem uptake genes, bhuRSTUV (Shalom
et al., 2007; Thomas, 2007), also referred to as hmuRSTUV, huvA-hmuSTUV
or omr-hmuSTUV (Yuhara et al., 2008; Kvitko et al., 2012; Tyrrell et al., 2015).
Note that in B. stagnalis a VOC family protein is encoded between bhuU and
bhuV, and in B. gladioli the bhu genes are organized into two operons present
on separate chromosomes. Gene loci of representative species are given in
Supplementary Table 4.
membrane receptor, a 75–85 kDa polypeptide that folds into a
β-barrel containing a central plug domain. Binding of a ferric-
siderophore complex to the external face of the receptor triggers
a conformational change in the gated receptor that allows access
of the complex to the periplasmic space. The energy required
for this process is derived from the proton motive force through
the action of the TonB system, a complex of three different
cytoplasmic membrane-anchored protein subunits: TonB, ExbB,
and ExbD (Noinaj et al., 2010; Celia et al., 2016). For this
reason, ferric-siderophore receptors are referred to as TonB-
dependent receptors (TBDRs) or TonB-dependent transporters
(TBDTs). As an example, OrbA is the TBDR for ferric-ornibactin
(Figure 5A). Once the ferric-siderophore complex has entered
the periplasmic space, the ferric ion is transported across the
cytoplasmic membrane, either in complex with the siderophore
or following release from the siderophore (depending on the
system). The cytoplasmic membrane transporters are often ATP-
binding cassette (ABC) transporters that consist of a periplasmic
binding protein, an intrinsic membrane protein (the permease)
and an ATPase located on the cytoplasmic face of the permease
(Krewulak and Vogel, 2008). This type of system operates for
the uptake of ferric ornibactin (Orb-B, -C, and -D) and possibly
also for cepaciachelin (CpcF, -I, and -J) in the Bcc, as well as for
the import of ferric malleobactin in B. pseudomallei and related
bacteria (Figures 5A,B; Agnoli et al., 2006). In the case of ferric-
pyochelin, a single subunit permease, FptX, appears to serve as
the cytoplasmic membrane transporter (Figure 5C; Cuiv et al.,
2004; Cunrath et al., 2015). For ferric-siderophore complexes that
enter the cytoplasm, the iron is removed from the siderophore
through its reduction to Fe(II), which is presumed to occur
for ornibactin (Agnoli et al., 2006), or through modification or
hydrolysis of the siderophore (Brickman and McIntosh, 1992;
Hannauer et al., 2010).
Like many other bacterial species, Burkholderia spp.
encode additional TBDRs that may allow them to utilize
siderophores that are produced by other bacteria and fungi
(“xenosiderophores”), although the potential importance of
these compounds for pathogenicity is only likely to be realized
in the context of a polymicrobial infection. Based on an
analysis of its translated genome, B. cenocepacia is predicted
to encode at least 20 TBDRs, many of which are likely to be
involved in utilization of xenosiderophores (our unpublished
results). At present, little is known concerning the nature of
the xenosiderophores that can be utilized by the Burkholderia.
However, the presence of the ornibactin transport genes in B.
paludis, but not the biosynthetic genes, strongly suggests that
ornibactin is likely to be utilized as a xenosiderophore by this
species.
Members of the Bcc also specify iron acquisition systems
that are not siderophore-dependent. For example, it has been
shown that B. cenocepacia can utilize haem as an iron source
(Whitby et al., 2006; Mathew et al., 2014; Tyrrell et al., 2015).
B. cenocepacia and B. multivorans contain a cluster of genes
(bhuRSTUV) that are predicted to be required for uptake of this
molecule (Figure 4C; Thomas, 2007; Yuhara et al., 2008). [Note
that there is currently a lack of consistency regarding the genetic
nomenclature for this system in the Burkholderia (see below and
legend to Figure 4).] Our bioinformatic survey shows that the
bhu cluster is present on chromosome 2 in nearly all Bcc species
for which whole genome sequence information is available
(Supplementary Table 4). The exception is B. vietnamiensiswhich
completely lacks the bhuRSTUV gene cluster. Although, there
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FIGURE 5 | Proposed iron uptake pathways in the Burkholderia. (A) The ornibactin/malleobactin uptake system. Ferric-ornibactin is recognized by the OrbA/MbaD
TBDR and is translocated into the periplasmic space through a conformational change in the plug domain of the TBDR that requires energy transduction by the TonB
complex (TonB-ExbB-ExbD). The iron-siderophore complex is then transported across the cytoplasmic membrane by a periplasmic binding protein-dependent ABC
transporter (OrbBCD/MbaLIJ). Oncethe ferric-siderophore complex has been internalized, iron is released from ornibactin through its reduction to the ferrous form by
OrbF/MbaK. (B) Ferric-cepaciachelin is proposed to require the CpcG TBDR. Genes neighboring cpcG encode a periplasmic binding protein-dependent ABC
transporter (CpcFHI) that may be involved in transport of the bis-catecholate complex across the cytoplasmic membrane. (C) Ferric-pyochelin uptake requires the
FptA TBDR and the single subunit cytoplasmic membrane transporter, FptX. (D) Uptake of haem via the Bhu system. Haem uptake is proposed to follow an
analogous pathway to that of ornibactin/malleobactin and cepaciachelin. Cytoplasmic haem is bound by the BhuS protein which is proposed to play a role in haem
trafficking and haemostasis. If required, iron can be released form haem by haem oxygenases (not shown). The FtrABCD system is not shown. OM, outer membrane;
CM, cytoplasmic membrane.
have not been any major studies carried out to investigate the
role of this system in haem acquisition in the Bcc, this function
has been established for the bhuRSTUV system in B. pseudomallei
(see below), and so one can confidently infer its role in haem
uptake in the Bcc. Haem appears to be an important source
of iron for P. aeruginosa during colonization of the CF lung,
and therefore one might expect members of the Bcc to take
advantage of this nutrient (Konings et al., 2013). B. cenocepacia
can also obtain iron from ferritin in a protease-dependent process
(Whitby et al., 2006; Mathew et al., 2014; Tyrrell et al., 2015).
Interestingly, although iron is present in the ferric form when
sequestered by ferritin, siderophores are not required for uptake
of ferritin-derived iron in B. pseudomallei (Kvitko et al., 2012).
Ferrous iron is very soluble and can passage across the
outer membrane of Gram-negative bacteria through porins in
an energy-independent process. However, it requires specific
transporters for translocation across the cytoplasmic membrane
in all bacteria. The Feo system is one such ferrous iron-specific
uptake system that is present in many Gram-positive and Gram-
negative bacteria (Lau et al., 2016). This system consists of a
cytoplasmic membrane transport protein (FeoB) and (in most
cases) a cytoplasmic component of unknown function (FeoA). In
some cases, a third component (FeoC) is also present. Ferrous
iron is likely to be an important source of this essential nutrient
for bacteria colonizing the CF lung based on its increased
abundance in the ASL of more severely afflicted CF patients.
Accordingly, it has been shown that the Feo system of P.
aeruginosa is upregulated during colonization of the lungs of
every individual in a cohort of 23 infected CF patients (Konings
et al., 2013). For this reason, we conducted a survey of human
pathogenic Burkholderia species for the presence of feoA and
feoB. However, only a small a minority of B. multivorans and B.
pseudomultivorans strains (not the type strains), as well as the
single currently identified B. paludis strain (MSh1), were found
to encode a FeoB-like protein, although these proteins lacked a
region of∼100 amino acids that is present in P. aeruginosa FeoB.
There were no matches when FeoA was used as the query in a
BLASTP search of the Bcc and B. pseudomallei. We conclude
that the vast majority of pathogenic Burkholderia species lack this
particular ferrous iron uptake system.
B. cenocepacia encodes a siderophore-independent
mechanism for iron assimilation that is very similar to the
FtrABCD systems reported in Bordetella and Brucella (Brickman
and Armstrong, 2012; Elhassanny et al., 2013; Mathew et al.,
2014). These systems share similarities with components of
the Escherichia coli EfeUOB system that serves to import
ferrous iron under aerobic conditions at low pH (Cao et al.,
2007). Accordingly, in Bordetella spp. and Brucella abortus,
ferrous iron is efficiently transported into these bacteria by
the FtrABCD system over the pH range 6.0–7.5, in a process
where the Fe(II) ion is oxidized to the ferric form using the
FtrB cupredoxin component before translocation across the
cytoplasmic membrane. In contrast, the B. cenocepacia FtrABCD
system appears to utilize ferric iron as the substrate. Given
the absence of a Feo system in B. cenocepacia, this begs the
question as to the mechanism by which this species can uptake
ferrous iron. B. multivorans also possesses an FtrABCD system,
but in contrast to that of B. cenocepacia it does utilize ferrous
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iron as the substrate (S.C. Andrews, unpublished results).
Therefore, it is possible that this systemmay play a role in ferrous
iron acquisition in the CF lung for at least some Bcc species,
particularly given the abundance of ferrous iron in combination
with the relatively low pH of CF ASL.
Although, the substantial proportion of iron that is in the
ferrous form and the increased abundance of haem in the
ASLmay implicate the siderophore-independent iron acquisition
mechanisms of the Bcc in establishing CF lung infections, as yet,
the role of these systems in the context of CF have not been
investigated in any detail (see below).
Experimental Evidence for the Role of Iron
Acquisition Systems in the Virulence of the
Bcc
In Vivo Studies
The earliest study on the role of iron acquisition mechanisms
in the virulence of members of the Bcc was carried out prior
to the discovery of the primary siderophore, ornibactin, in this
group of bacteria (Sokol, 1986). Here, it was observed that from
a collection of 43 “P. cepacia” CF isolates, ∼50% produced
detectable levels of pyochelin during iron limited growth in
vitro (Pch+ phenotype). However, 86% of the Pch+ strains were
associated with infections which had led to the death of the
patient or were responsible for severe infections, whereas only
41% of Pch− strains were associated with such outcomes. Thus,
while the ability to colonize a CF patient could not be linked
to the ability to produce this siderophore, there was a link
between pyochelin production and the morbidity/mortality of
disease in CF patients. Similarly, while addition of exogenous
pyochelin to two pyochelin-negative Bcc strains did not increase
bacterial numbers or bacterial persistence in infected rat lungs,
it did increase the severity of infection as assessed by lung
pathology (Sokol and Woods, 1988). It was proposed that
the observed enhancement of lung damage brought about by
exogenous addition of pyochelin to these strains was most
likely due to increased dissemination of the bacteria throughout
the lungs. However, it is not clear from these studies whether
it was the role of pyochelin in iron acquisition that was
responsible for the more severe outcome or some other effect
of the siderophore. In this regard, it is known that apart
from binding iron and other metals (Cuppels et al., 1987;
Visca et al., 1992; Baysse et al., 2000; Braud et al., 2009)
pyochelin possesses an inherent chemical reactivity that may
contribute to disease severity. For example, it can promote the
degradation of organotin derivatives (Sun et al., 2006), and
perhaps pertinently, it can catalyse the generation of ROS such
as hydroxyl radicals that result in tissue damage (Coffman et al.,
1990; Britigan et al., 1994, 1997; Adler et al., 2012). The latter
property is proposed to contribute to the known antibiotic
activity of this siderophore (Adler et al., 2012; Ong et al., 2016).
It should be noted that one important Bcc pathogen of CF
patients, B. multivorans, does not produce pyochelin (Table 1)
and the clonally related B. cenocepacia CF epidemic strains
K56-2 and J2315 produce very little of this siderophore (see
below).
A direct genotypic-phenotypic link between iron acquisition
and the virulence of B. cenocepacia was observed during an
investigation of the virulence potential of ornibactin deficient
mutants in rodent models of both chronic and acute respiratory
infection (Sokol et al., 1999). In this study, mutants derived
from the highly transmissible epidemic B. cenocepacia strain,
K56-2, which contained an insertionally inactivated pvdA
gene that is required for ornibactin synthesis (Figure 3), were
generated by transposon mutagenesis (pvdA::Tn5-OT182) and
allelic replacement (pvdA::tp). Both mutants were significantly
attenuated in these models. Thus, in a rat lung chronic infection
model, the number of pvdA::Tn5-OT182 bacterial cells recovered
from the lung was 4 logs lower than that of the wild type K56-
2 strain at 28 days post infection. Furthermore, the pvdA::tp
strain could not be recovered from the lungs after the same
length of time, suggesting the infection had been cleared.
The degree of pathology, as determined by the amount of
inflammatory cell infiltration and exudate in the lungs, was
also significantly reduced in the K56pvdA::tp strain compared
to that of K56-2. Aerosol administration of K56-2 and the
pvdA::Tn5-OT182 mutant into neutropenic mice as an acute
respiratory infection model revealed that whereas the wild type
strain was able to persist in the lung 7 days post infection,
the pvdA mutant was cleared from most of the mice after 3
days. These experiments suggested the importance of ornibactin-
mediated iron acquisition by the bacteria for initial colonization,
persistence and resulting pathological changes within the host.
However, given the difference in the iron content of the lungs of
a healthy individual compared to those of a CF patient, it is not
clear to what extent the conclusions from this study, which did
not involve CF mice or rats, can be extrapolated to the situation
in the CF lung.
While the data indicated an important role for ornibactin
in lung colonization in these models, the K56-2 strain (and
other members of the highly transmissible ET12 epidemic
lineage) produces very low amounts of the siderophore pyochelin
compared to other B. cenocepacia strains due to a frameshift
mutation in pchF (Darling et al., 1998; Holden et al., 2009)
(Based on perusal of the genome sequence, we presume pyochelin
biosynthesis in these strains occurs through independent
initiation of translation from an internal in-frame GUG codon
located upstream of the frameshift site that results in production
of PchF as two separate components). Thus, the role of pyochelin
in the lung infection model could not be established using ET12
strains. However, given that ET12 strains cause life-threatening
infections in CF patients, this would again appear to rule out
an important role for pyochelin in colonization of the CF lung
by B. cenocepacia. Later work using a B. cenocepacia strain
(Pc715jorbA::tp) that produced normal amounts of pyochelin but
was unable to utilize ferric-ornibactin due to disruption of the
gene encoding the ferric-ornibactin TBDR, OrbA, revealed that
it was cleared from rat lungs much more quickly than the WT
strain (Visser et al., 2004). A ferric-pyochelin receptor mutant
(Pc715jfptA::tp) persisted with the same efficiency as that of the
WT. These data suggested that while pyochelin may have a role
in the severity of infection, it is unable to compensate for the
loss of a functional ornibactin utilization system. Therefore, it is
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ornibactin which appears to be important in order to establish an
infection in this system. This may be explained by the presumed
lower affinity of pyochelin than ornibactin for iron (Cox and
Graham, 1979; Visca et al., 1993).
The importance of the ornibactin system for the virulence of
B. cenocepacia has also been assessed in other infection models,
including invertebrates and plants. Both a K56-2 orbA mutant
and a K56-2 pvdAmutant were attenuated in the Caenorhabditis
elegans and Galleria mellonella invertebrate models. The pvdA
mutant was also slightly attenuated in the plant alfalfa model
(Uehlinger et al., 2009). An orbJ mutant of the B. cenocepacia CF
strain, H111, that is also deficient in the production of ornibactin,
was also attenuated in the G. mellonella system (Mathew et al.,
2014). Consistent with the virulence of the K56-2 strain in the
rat lung chronic infection model, an H111 1pchAB pyochelin
deficient mutant was still virulent in G. mellonella.
Using a modified signature-tagged mutagenesis (STM)
procedure to identify genes required for survival in the
rat chronic lung infection model, one of the attenuated B.
cenocepacia K56-2 mutants which could not survive for 10 days
in this model contained a transposon inserted just upstream of an
ORF that encoded a haem TBDR-like protein (Hunt et al., 2004).
The authors of this study indicated that the gene was the first in a
cluster of genes associated with haem uptake that were located
on chromosome 2, and the encoded protein was very similar
to the 79 kDa RS03722 gene product of Ralstonia solanacearum
strain GMI1000 (now reannotated as RSp0244). As RSp0244 is
highly similar to BhuR we conclude that the plasposon insertion
exerted polar effects on expression of the bhuRSTUV operon
that impaired or abolished haem uptake. In contrast, genes
involved in the biosynthesis and transport of ornibactin and
pyochelin were not implicated in this study (Hunt et al., 2004).
These observations would suggest that haem acquisition, and
not siderophore-mediated iron acquisition, is an essential trait
for persistence in the rat lung. Notwithstanding the different
time courses of the chronic lung infection models, it is not clear
why the ornibactin system should be implicated in some studies
(Sokol et al., 1999; Visser et al., 2004) but not in the STM study,
particularly as the ornibactin gene cluster presents a large target
for plasposon-mediated disruption. One possible explanation is
the selection procedure employed to construct the B. cenocepacia
transposon mutant library. Here, mutants were selected on a
mineral salts based medium in order to exclude auxotrophs.
A K56-2 mutant in which the plasposon has disrupted a gene
required for ornibactin synthesis or utilization would effectively
be unable to obtain iron in a siderophore-dependent manner.We
have observed that B. cenocepacia siderophore deficient mutants
grow more slowly that the parental wild type strain on mineral
salts medium (see for example Asghar et al., 2011), and it is
possible that such mutants were omitted from the library of Hunt
et al. This is not a complete explanation, however, as the haem
uptake deficient mutants in the STM study can still produce
ornibactin and so they might be expected to retain virulence
based on other studies. This may suggest that a combination of
both iron acquisition systems (haem- and ornibactin-mediated)
is required for efficient colonization and persistence in the rat
lung model.
Finally, the B. cenocepacia FtrABCD system was also
investigated for a potential role in virulence in the Galleria wax
moth model. Whereas deletion of the ftr system in isolation did
not result in reduced virulence, when deleted in a strain that
was unable to biosynthesise ornibactin and pyochelin, themutant
was more attenuated in comparison to an ornibactin-negative
strain. This observation suggests that while ornibactin is themore
important iron acquisition system for virulence in this model,
the FtrABCD system can play a role in iron acquisition during
infection in the absence of siderophores (Mathew et al., 2014).
In Vitro Studies
Changes in the environmental iron concentration or availability
can also trigger adaptive changes in expression of virulence traits
that are not directly connected to iron acquisition but rather serve
other roles that contribute to survival of the bacterium under
the prevailing conditions. Such examples include regulating
biofilm formation in P. aeruginosa and capsule production in
Cryptococcus neoformans (Singh et al., 2002; Banin et al., 2005;
Jung et al., 2006). For B. cenocepacia it has been shown that
modulating the concentration of iron causes a switch from
planktonic to sessile growth. Thus, supplementing liquid cultures
with ferric iron concentrations ranging from 1 to 100µM
resulted in increased levels of extracellular matrix production by
strain PVI as the iron concentration was increased. Furthermore,
biofilm formation induced by growth under high iron conditions
resulted in more efficient invasion of A549 epithelial monolayers
compared to cells grown in lower iron conditions that did not
produce biofilm (Berlutti et al., 2005). In contrast, adherence of B.
cenocepacia to A549 cells was more efficient under iron limiting
conditions. The consequences of this for B. cenocepacia CF lung
infections are not yet clear.
Gene Expression and Omics Studies
Transcriptomic and proteomic analyses can be used to identify
sets of genes or proteins that may be required for survival under
particular conditions by virtue of their differential expression. A
few such studies have been carried out with B. cenocepacia that
have suggested an important role for iron uptake mechanisms
in bacterial persistence within CF patients. However, as we
discuss below, the experimental set up may not necessarily be
appropriate for addressing this particular question. The first
notable study looked at global gene expression during growth of
B. cenocepacia J2315 in a basal salts medium supplemented with
CF sputum in comparison to growth in unsupplementedmedium
(Drevinek et al., 2008). The microarray revealed upregulation of
287 genes and downregulation of 437 other genes during growth
in CF sputum medium. However, only two of the upregulated
genes were associated with characterized iron acquisition systems
in this bacterium. These two genes (pchR and pchD) encode
the transcription activator of the pyochelin gene cluster and an
enzyme required for biosynthesis of the pyochelin precursor,
salicylic acid, respectively, but their expression increased only 2-
fold. Transcription of the ornibactin genes was not upregulated,
although the gene encoding the global iron repressor, Fur,
that represses the ornibactin gene cluster, was found to be
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 11 November 2017 | Volume 7 | Article 460
Butt and Thomas Role of Iron Acquisition in the Virulence of Burkholderia
downregulated 2- to 3-fold (Agnoli et al., 2006; Drevinek et al.,
2008).
The authors of this work measured the iron content of
their sputum medium and found it to be ∼35µM, which is
more than adequate to sustain growth of B. cenocepacia in
standard laboratory medium without upregulating siderophore
biosynthesis (Drevinek et al., 2008; Madeira et al., 2013; our
unpublished results). Despite the presence of CF sputum in
the medium, which has been argued by some investigators to
sequester iron due to the presence of various iron binding
components (Wang et al., 1996; Palmer et al., 2007), their results
imply that sufficient iron is available to effect repression of the
ornibactin system. Accordingly, the observed induction of the
pch genes may not be related to iron depletion but is rather a
response to the presence of another component in CF sputum.
It is noteworthy that genes encoding other components of the
pyochelin biosynthesis machinery (particularly those enzymes
required to assemble pyochelin from salicylate and cysteine)
and alternative iron uptake systems (FtrABCD and BhuRSTUV)
were also not upregulated. The authors contend that the CF
medium they employed restricted the available iron based on the
observed gross upregulation of the BCAL0270 gene, which they
considered to be involved in iron acquisition (described in the
study as a “ferric reductase-like transmembrane component”).
However, in a basal salts medium without iron supplementation,
this gene was upregulated only 2-fold compared to medium
containing the standard amount of ferrous sulfate (43µM).
Moreover, this gene is currently annotated in the NCBI database
as encoding a “sulfoxide reductase heme-binding subunit YedZ”
and it is transcriptionally linked to BCAL0269, a gene that
encodes a YedY-homologous protein. Our own bioinformatics
analysis supports this annotation (results not shown). The E. coli
YedYZ complex is a membrane anchored haem-molybdoenzyme
that serves to reduce an as yet unknown S- or N-oxide (Iobbi-
Nivol and Leimkuhler, 2013). Therefore, there is little evidence
to support the suggestion that BCAL0270 is involved in iron
acquisition. The possibility that the CF sputum medium of
Drevinek et al. (2008) is iron sufficient accords with the high
iron concentration included in the basal salts medium used to
generate the medium. Notwithstanding the fact that the sputum
is present at only 10% (w/v) in the medium, the inability of the
added CF sputum to induce iron acquisition systems may suggest
that its ability to sequester iron is somewhat limited and/or it is
iron replete.
The results of Drevinek et al. (2008) contrast with those of
Palmer et al. (2005), who monitored gene expression in the CF
pathogen P. aeruginosa growing in a mineral salts based medium
containing only CF sputum as the source of carbon and energy
(“MOPS-sputum medium”), and noted that a large number
of genes specifying the biosynthesis of the major siderophore,
pyoverdine, as well as the entire cluster of genes specifying
the biosynthesis and transport of the secondary siderophore,
pyochelin, were considerably upregulated relative to their
transcription in cells growing in sputum-free MOPS-glucose
medium. However, although MOPS-sputum medium contained
a similar amount of CF sputum to that used by Drevinek et al.
(2008), the iron content (3.5µM)was approximately one tenth of
that present in themedium used in the B. cenocepacia experiment
(in both cases iron was added as ferrous sulfate). Thus, although
it should be borne in mind that two different CF pathogens are
being compared, each possessing a different primary siderophore
system, the amount of iron added ranged from iron replete (in the
B. cenocepacia experiment) to a concentration that will support
bacterial growth but may require a degree of upregulation of
the siderophore-mediated iron acquisition system (in the P.
aeruginosa experiment), (pyoverdine synthesis is fully repressed
at ∼4µM iron and is upregulated to a progressively greater
degree as concentrations of iron are decreased below 4µM;
Meyer and Abdallah, 1978). The reader may wish to consider
which version of CF sputummediummore closely represents the
true environment of the CF lung with respect to iron availability.
The other variable at play that may influence the iron content is
the source of the sputum. As discussed above, the iron content of
sputum shows marked variation among CF patients, particularly
in relation to the severity of the disease (Stites et al., 1998;
Reid et al., 2002; Hunter et al., 2013). To illustrate the potential
for a different outcome that may reflect variation in the iron
content of CF sputum, in an IVET study conducted on P.
aeruginosa growing in a mineral salts medium containing 10%
CF mucus, and otherwise with no iron supplementation, only a
single iron-regulated gene, fptA (encoding the ferric-pyochelin
outer membrane receptor), was identified as being upregulated
(Wang et al., 1996).
Global changes in B. cenocepacia gene expression have also
been analyzed in a synthetic CF sputum medium (SCFM).
SCFM is a defined (i.e., sputum-free) medium containing the
average concentrations of ions, free amino acids, glucose and
lactate as those found in the sputum of CF patients and
has been shown to support similar growth rates and elicit
similar changes in expression of some subsets of genes in
P. aeruginosa to those observed during growth in MOPS-
sputum medium (Palmer et al., 2007). It also contains 3.6µM
ferrous iron (i.e., similar to that of MOPS-sputum medium).
Although the iron concentration of SCFM may be low enough
to cause upregulation of P. aeruginosa siderophore gene
expression relative to iron replete conditions, these genes were
not (unsurprisingly) upregulated relative to cells growing in
a MOPS-glucose based mineral salts medium containing an
almost identical concentration of iron (Palmer et al., 2007). The
contrasting high level of siderophore gene expression observed
in P. aeruginosa growing in MOPS-sputum medium relative to
cells growing in MOPS-glucose medium (Palmer et al., 2005)
was rationalized on the basis that CF sputum also contains iron
sequestering components which have been proposed to restrict
the availability of iron (Palmer et al., 2007). Other analogous
attempts to mimic CF sputum conditions using semi-synthetic
media, such as ASMDM or Modified ASMDM, and comparing
gene expression in P. aeruginosa to that in cells growing
in standard laboratory media have likewise not suggested a
requirement for the main siderophore-mediated iron acquisition
systems in synthetic sputum-like media [apart from one case
where a small (2-fold) increase in some pyochelin biosynthesis
and transport genes was observed; Fung et al., 2010; Hare et al.,
2012].
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In apparent contrast to the observations with P. aeruginosa,
the entire ornibactin gene cluster of B. cenocepacia, as well as
genes encoding a number of TBDRs and a cluster of genes that
encode a putative bacterioferritin-associated ferredoxin and a
TonB system (BCAL2290-BCAL2293) were found to be strongly
upregulated during growth of B. cenocepacia J2315 in SCFM
in comparison to growth in soil extract medium, although the
pyochelin biosynthesis genes were not upregulated in SCFM
(Yoder-Himes et al., 2010). These results also contrast with those
observed for B. cenocepacia growing in a basal salts medium
supplemented with glucose, casamino acids and CF sputum (see
above; Drevinek et al., 2008). The most likely reason for the latter
difference is that there was a 10-fold higher concentration of iron
in the CF sputum medium in comparison to SCFM. It might
seem intriguing that SCFM stimulates ornibactin gene expression
in B. cenocepacia but not expression of pyoverdine genes in P.
aeruginosa. However, again one must proceed with caution in
interpreting these data, as the fold induction of gene expression
in P. aeruginosa cells growing in SCFM was expressed relative
to medium containing the same iron concentration, whereas
the comparator for the B. cenocepacia experiment were cells
growing in soil extract medium, which has an indeterminate
iron concentration. In fact, it is likely that relative to cells
growing in an iron replete, nutrient rich laboratory medium,
both the pyoverdine and ornibactin gene clusters may actually
be upregulated in cells growing in SCFM.
To summarize the above, it is difficult to make informed
judgements regarding the requirement or otherwise for various
iron acquisition systems based on gene expression analysis in
cells growing in defined or semi-defined media that seek to
mimic CF conditions when the concentration of iron and its
relative availability may not accurately reflect the situation in
the patient. As an example, we note that in some more recent
attempts to mimic CF conditions using synthetic media, a higher
iron concentration has been used by including ferritin to better
reflect the prevailing view that the iron content of the CF lung
is relatively high (Hare et al., 2012). Moreover, experiments
involving media which incorporate CF-derived sputa may be
prone to a high degree of experimental variation according to
the disease severity and consequential iron status of the sputa.
Finally, obvious though this must appear, consideration of the
comparator is fundamentally important in assessing whether or
not iron acquisition genes are upregulated in such media.
The difficulty in reproducing CF conditions in vitro can be
bypassed by measuring gene expression in bacterial pathogens
that are present in sputum following collection of samples from
CF patients. As an example, in one such study, a microarray
experiment was performed using P. aeruginosa mRNA isolated
from sputum obtained from a single patient (Son et al., 2007). In
this investigation, genes specifying the biosynthesis of pyochelin
were upregulated but not those encoding the biosynthesis and
transport of the major siderophore pyoverdine. In a later study,
an RT-qPCR analysis of gene expression in P. aeruginosa strains
that were present in the lungs of a cohort of CF patients suggested
that the siderophore pyoverdine was likely to contribute to iron
acquisition in this context (Konings et al., 2013), and indeed
the presence of the siderophore could be detected in CF sputa
(Martin et al., 2011). In contrast, to our knowledge, studies
involving direct sampling of RNA from Bcc bacteria colonizing
the CF lung have not been carried out. However, sampling
of B. cenocepacia mRNA directly from an animal model of
a chronic lung infection has been carried out (O’Grady and
Sokol, 2011). As discussed earlier, the ability to biosynthesise
ornibactin plays an important role in chronic infections of
the rat lung by B. cenocepacia (7 and 14 days post-infection;
Visser et al., 2004). However, microarray data in which gene
expression in B. cenocepacia K56-2 cells that were recovered
from the rat lung model 3 days post-infection was compared
to cells that were grown to stationary phase in a nutrient-rich
broth (iron replete medium), showed no difference in ornibactin
gene expression levels (O’Grady and Sokol, 2011). Therefore,
the simplest interpretation of these data is that ornibactin is not
required to establish an infection in this particular model system
but it is required for persistence. Moreover, in contrast to the
STM analysis of Hunt et al. (2004), the microarray analysis did
not reveal a difference in expression of the bhuR and bhuS genes
(referred to as huvA and hmuS by the authors) in the rat lung
model compared to growth in iron replete medium (O’Grady and
Sokol, 2011). As the STM study was conducted with animals that
were infected for 10 days, one possible explanation is that haem
utilization becomes important for longer term infections as has
been observed in P. aeruginosa (see below).
Transcriptomics has been used to monitor B. cenocepacia
adaptation to the host over time, although in this case RNA
was isolated following in vitro culture of the bacteria. In one
such study, gene expression was compared in two clonal variants
that were isolated 3 years apart from a CF patient who died of
cepacia syndrome. This study revealed that in the later clone,
seven genes located within the ornibactin gene cluster were
upregulated 1.9- to 5.9-fold compared to those in the earlier
isolate when both strains were cultured on a nutrient-rich agar.
Other genes potentially involved in iron uptake were also found
to be more transcriptionally active in this isolate, including three
genes that encode TBDRs that are not involved in ornibactin
or pyochelin uptake, and two genes, bhuR and bhuS (referred
to as huvA and hmuS by the authors), from the bhuRSTUV
gene cluster that is proposed to be required for the uptake of
haem (Figure 4C; Mira et al., 2011). A subsequent proteomic
study employing the same pair of isolates, along with a third
isolate collected just before the death of the patient, showed
that the two later isolates exhibited an increased abundance
of four proteins involved in siderophore-mediated iron uptake
compared to the earliest clone (Madeira et al., 2013). These
proteins included two TBDRs (one of which was FptA) that
had increased in abundance by <2-fold, and one component of
the ferric-ornibactin cytoplasmic membrane transporter (OrbC)
which showed a relatively small increase in abundance (∼50%)
in the third isolate compared to the first. However, in contrast to
the transcriptomic study, a general increase in abundance of iron
acquisition proteins was not observed. Moreover, based on a CAS
assay, the latter two isolates were considered to be more tolerant
to low iron concentrations (siderophore production was induced
at 4 or 5µM iron, whereas in the primary isolate siderophore
production was upregulated at 6µM iron).
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In a later study carried out on the same sequential clonal
isolates, the upregulation of ornibactin gene expression observed
in response to the iron chelating activity of exogenously added
pyoverdine was significantly less pronounced in the last isolate
compared to the earlier isolates (Tyrrell et al., 2015). These
observations are consistent with a scenario in which selection
for genetic alterations has occurred upon long term colonization
of the CF lung that lead to a decreased reliance on siderophore-
dependent iron acquisition by the bacterium. This may indicate a
switchover to another means of iron acquisition or it may reflect
a general downregulation of iron acquisition mechanisms due to
increased inflammatory damage that occurs in the CF lung as
the disease progresses and the consequent increased availability
of iron (Cohen and Prince, 2012).
The results are analogous to those obtained from studies
carried out on P. aeruginosa, in which it was observed that
during infection of the CF lung mutations accrue in the bacterial
population that result in a reduction or abolition of production of
the major siderophore, pyoverdine (Marvig et al., 2014; Nguyen
et al., 2014 and refs within). Evidence was also provided for
increased haem usage as an iron source concomitant with a
reduction in pyoverdine synthesis during the later stages of
infection (Marvig et al., 2014; Nguyen et al., 2014). Consistent
with this, in a separate microarray study carried out on mRNA
isolated directly from a P. aeruginosa-infected CF patient, two
genes from the pyochelin gene cluster (pchA and pchC) were
observed to be upregulated 2- to 3-fold, but no pyoverdine
genes were identified as being upregulated (Son et al., 2007).
Although these results were obtained from work on a different
CF pathogen, they are consistent with the idea that siderophore-
mediated iron acquisition in the CF lung may not be of major
importance to some pathogenic bacteria, particularly later on in
an infection.
While these types of analyses may provide useful pointers as
to the iron acquisition mechanisms that may be employed by
pathogenic bacteria colonizing the CF lung, particularly if the
isolate has accrued mutations that have inactivated a particular
uptake system, the fact that these systems are subject to genetic
regulation means that a true understanding of the iron uptake
mechanisms at play during an infection will also require analysis
of bacterial gene expression in vivo, i.e., in the CF lung.
Studies on the effects of other environmental parameters
on global gene expression in B. cenocepacia have also been
conducted that have potential implications for iron acquisition
in this organism. In one investigation, the effect of oxygen
depletion on gene expression was assessed, as there is evidence
to suggest that within the CF lung a steep oxygen gradient is
generated due to increased activity of airway epithelial Na+-K+-
ATPase pumps and excessive mucin secretion. This results in
the deepest layers of mucus providing a hypoxic environment
that can support high densities of micro-oxic and anaerobic
microbes in the CF lung (Tunney et al., 2008). In this study
it was shown that B. cenocepacia can grow in an atmosphere
with oxygen concentrations as low as 0.1% (Pessi et al., 2013).
The possibility that B. cenocepacia may therefore occupy a low
oxygen niche when colonizing the lungs of CF patients prompted
an RNA-seq and shotgun proteome analysis of B. cenocepacia
H111 growing under micro-oxic conditions (0.5% oxygen) in
comparison to aerobic growth (21% oxygen). RNA-seq showed
strong down regulation of the pyochelin biosynthesis genes
pchD, pchE, and pchF in addition to the gene encoding the
ferric-pyochelin outer membrane receptor, FptA, in micro-oxic
conditions. Overall production of siderophores was also reduced
in micro-oxic conditions as assessed by the CAS agar assay (Pessi
et al., 2013). This kind of environment promotes the increased
stabilization of Fe(II) and may favor the use of ferrous iron
transport systems, such as the FtrABCD system in B. multivorans,
over siderophore based systems.
Another environmental parameter that appears to affect the
expression of iron acquisition genes that may be pertinent in the
context of CF lung infections is oxidative stress. Thus, it has been
observed that exposure of B. cenocepacia biofilms to hydrogen
peroxide causes increased expression of the first few genes of
the ornibactin gene cluster (orbS, orbH, and orbG; Peeters et al.,
2010). While the oxygen and oxidative stress status of the niche
occupied by B. cenocepacia in the CF lung has not yet been
established, these observations bring into focus the requirement
to mimic, as close as possible, the conditions of the CF lung when
assessing the potential role of iron acquisition mechanisms in the
virulence of respiratory pathogens.
To summarize, there appears to be a role for ornibactin-
mediated iron acquisition in the virulence of B. cenocepacia in
both vertebrate and invertebrate models of infection, including
infections of the respiratory tract. However, in the context of a
CF infection the role of ornibactin is less certain and there is a
possibility that haem acquisition may come into play. Moreover,
the severity of the disease and the particular niche that is occupied
by Bcc bacteria in the lung—for example, whether it is oxygen
rich or hypoxic—are also likely to dictate which iron acquisition
mechanism(s) are primarily deployed. Currently, there is little
evidence to support a role for the secondary siderophores in
colonization and persistence by Bcc bacteria, although this is
partly due to the fact that no studies on the possible roles
of cepaciachelin and cepabactin have been reported. Further
studies are required to establish the relative importance of the
various iron acquisition mechanisms available to Bcc bacteria for
colonization of the CF lung.
BURKHOLDERIA PSEUDOMALLEI AND
BURKHOLDERIA MALLEI
B. pseudomallei is both an environmental saprophyte and the
causative agent of the tropical disease melioidosis (Wiersinga
et al., 2006). This disease is endemic in South East Asia and
Northern Australia with sporadic cases increasingly reported in
other topical regions (Perumal Samy et al., 2017). Contraction
of the disease is via cuts and abrasions, inhalation or ingestion
(Wiersinga et al., 2012). Although apparently healthy individuals
can become infected, conditions such as diabetes and liver disease
are highly associated risk factors of melioidosis (Perumal Samy
et al., 2017). The disease manifests in a range of forms from
acute infections, chronic reoccurring infections, fatal sepsis or
even persistent asymptomatic infections lasting for up to 60 years
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(White, 2003; Ngauy et al., 2005). The lung is the most commonly
infected organ with the liver, spleen, skeletal muscle and prostate
other sites of infection (White, 2003).
B. mallei is a host restricted obligate pathogen with no known
environmental reservoir (Whitlock et al., 2007). This bacterium
causes the zoonotic disease glanders, which is spread directly or
indirectly through secretions and excretions of infected animals.
This disease is chronic in horses and an acute form of the
disease occurs in donkeys and mules. Infection of humans is
rare and is usually the result of occupational exposure (Verma
et al., 2014). B. mallei is considered to be a clone of B.
pseudomallei that has undergone a process of genome reduction
during host adaptation (Godoy et al., 2003; Nierman et al.,
2004).
Experimental Evidence for the Role of Iron
Acquisition Systems in the Virulence of B.
pseudomallei
The role of iron in B. pseudomallei and B. mallei virulence has
been less well-studied than in B. cenocepacia mainly due to
the increased hazard associated with handling these organisms
which necessitates a more stringent level of containment and has
also restricted the range of available selective genetic markers.
Nevertheless, with the recent development of biosafety compliant
tools for the genetic manipulation of these bacteria important
progress has been made in our understanding of their iron
acquisition systems and the role that these systems play in
virulence. It is now well-established that access to iron is
important for virulence by B. pseudomallei. For example, it has
been demonstrated that the severity of B. pseudomallei infection
of A549 macrophages and HeLa cells is increased if the cell
lines are supplemented with iron. Thus, B. pseudomallei K96243
formed more plaques on iron-supplemented HeLa cells and
invasion was significantly increased in iron-supplemented A549
cells. Furthermore, the intracellular survival of B. pseudomallei
in A549 monolayers and the ability to induce MNGC formation,
was greater when the A549 monolayers were supplemented with
iron compared to non-iron supplemented controls (Amornrit
et al., 2012). Interestingly, iron has also been shown to down
regulate one of the type VI secretion systems (specifically
T6SS-5) in B. pseudomallei and B. mallei (Burtnick and Brett,
2013). T6SS-5 is essential for virulence in hamsters and is
required for multinucleated giant cell formation in infected
tissue culture monolayers, a phenomenon that may facilitate
cell-to-cell spread of the bacterium (Burtnick et al., 2011)
[Note: T6SS-5, as designated by Shalom et al. (2007), is also
referred to as T6SS-1 or the cluster 1 type VI secretion
system by some authors (Schell et al., 2007; Burtnick et al.,
2011)].
A limited number of studies have been carried out to
determine the role of siderophores and other iron uptake
systems on the virulence of B. pseudomallei and B. mallei. Both
species produce the siderophore malleobactin (or more precisely,
malleobactin E), that is structurally related to ornibactin (Yang
et al., 1991; Alice et al., 2006; Franke et al., 2013, 2015;
Figure 2). This siderophore was shown to be able to acquire
iron from human transferrin and lactoferrin (Yang et al.,
1993). B. pseudomallei, like several members of the Bcc, also
produces pyochelin as a secondary siderophore (Alice et al.,
2006; Kvitko et al., 2012), whereas in B. mallei, which has
undergone extensive genome reduction, the gene cluster needed
for pyochelin production is absent (Esmaeel et al., 2016). This is
consistent with other evidence that pyochelin has a limited role in
Burkholderia virulence, and loss of the ability to manufacture this
siderophore in B. mallei may point to a more important role of
pyochelin in environmental survival among other Burkholderia
species. Moreover, B. mallei also produces reduced levels of
malleobactin (as determined by the CAS assay) compared to
B. pseudomallei and B. thailandensis which may also reflect the
narrower range of niches in which it inhabits (Ong et al., 2004).
B. pseudomallei may also secrete a third compound with iron
chelating activity, although this compound has not yet been
characterized (Kvitko et al., 2012).
The BPSS0240-BPSS0244 genes of B. pseudomallei K96243
were proposed to serve as a haem uptake system and were
observed to be upregulated during growth under low iron
conditions (Tuanyok et al., 2005). Based on an IVET screen,
this system was shown to be induced during growth of B.
pseudomallei NCTC 10274 within macrophages, suggesting that
it may play an important role in iron acquisition during
intracellular survival. In this study the authors referred to
the uptake system as the Bhu (Burkholderia haem uptake)
system based on the Pseudomonas Phu system (Shalom et al.,
2007). By analogy with the Phu system and the related Shu
system of Shigella, the Bhu system consists of the TBDR,
BhuR (BPSS0244), a periplasmic binding protein-dependent type
II ABC transporter (BhuT-BhuV) for translocation of haem
across the cytoplasmic membrane, and a cytoplasmic haem
binding protein (BhuS) that plays a role in haem trafficking
and may also initiate haem degradation (Figure 5D; O’Neill
and Wilks, 2013; Naoe et al., 2016; see Choby and Skaar,
2016) for a review. Based on a bioinformatic analysis, B.
pseudomallei K96243 was predicted to specify two additional
outer membrane receptors for haem (BPSL2724 and BPSS1742)
with the former also associated with an ABC transporter
system (Harland et al., 2007). However, neither of these
systems shows a strong homology to characterized haem uptake
systems. The BPSL2721-BPSL2724 and BPSS0240-BPSS0244
(Bhu) transport systems were later referred to as the Hem
and Hmu systems, respectively, in a study conducted on
strain 1710b (Kvitko et al., 2012). These authors observed
that whereas deletion of the bhu/hmu locus compromised
the ability of B. pseudomallei to utilize haem or hemoglobin
as iron sources, deletion of the hem locus did not abrogate
the ability to utilize haem, strongly indicating that the
Bhu/Hmu system serves as the haem uptake system in this
organism.
Kvitko and colleagues went on to explore the relative
contributions of siderophore- and haem-mediated uptake
systems to B. pseudomallei virulence in an acute murine
melioidosis model following intranasal infection. They found
that although utilization of lactoferrin-bound iron in vitro
relied on malleobactin, inactivation of the malleobactin uptake
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system in strain 1710b did not cause attenuation in the murine
melioidosis model (Kvitko et al., 2012). Interestingly, a strain
that was defective for malleobactin, pyochelin, and haem uptake
was also fully virulent in the melioidosis model, although the
titres of bacteria recovered from some organs was significantly
lower. As this mutant could still grow with ferritin as an
iron source, it was suggested that another iron uptake system
is present that could compensate for the loss of the other
uptake pathways. There are at least two possibilities that could
account for this. First, the CAS agar assay indicated that
B. pseudomallei mutants lacking the ability to biosynthesise
malleobactin and pyochelin specify an additional secreted iron-
chelating compound of unknown identity (Kvitko et al., 2012).
Secondly, B. pseudomallei encodes the FtrABCD system which
may play a role in iron acquisition during infection (Mathew
et al., 2014). Perhaps surprisingly, although B. pseudomallei
708a (a strain containing a >130 kb genome deletion that
removes the malleobactin synthesis genes) was virulent in
the mouse model used by Kvitko and colleagues, it was
attenuated in G. mellonella (Wand et al., 2011; Kvitko et al.,
2012).
The outer membrane receptors required for uptake of ferric-
siderophore complexes and haem require the action of the
cytoplasmic membrane-anchored TonB-ExbB-ExbD complex to
energize transport of these iron sources. A B. mallei tonB
mutant, which is unable to internalize ferric-malleobactin or
haem, was shown to be completely attenuated in mice at 105
CFU, in comparison to an LD50 of 7.4 x 10
4 CFU for the
wild type, and it also exhibited lower titres in target organs
(lungs and spleen). Supplementation of the medium with ferrous
iron, which is assimilated by a TonB-independent mechanism,
partially restored virulence and led to higher titres of tonBmutant
bacteria in the spleen, indicating that the inability to acquire iron
is the main reason for the loss of virulence in the mutant (Mott
et al., 2015). However, as TonB systems in other species have
been shown to be involved in transport of other large molecules,
including some enzyme cofactors (thiamine, cobalamin) and
saccharides (sialic acid, sucrose, maltodextrins) the possibility
exists that there are other transport requirements served by the B.
mallei TonB system that must be met for full virulence (Schauer
et al., 2008; Roy et al., 2010).
Another study in which potential novel therapeutics were
screened for their ability to counteract B. pseudomallei killing
of C. elegans suggested an important role for iron acquisition
in virulence. Exposure of B. pseudomallei to the plant alkaloid
curcumin (diferuloylmethane), prior to their administration to
C. elegans, significantly enhanced the survival of the worms
(Eng and Nathan, 2015). Curcumin is structurally related to
bis-catecholates, which include bacterial siderophores such as
azotochelin, cepaciachelin, and serratiochelin, and is itself a
known iron chelator that may serve to cause a decrease in
iron availability (Jiao et al., 2006). Accordingly, microarray data
showed that B. pseudomallei treated with curcumin upregulated
genes for iron transport, including those for malleobactin,
pyochelin and haem uptake, as well as genes encoding the
TonB system. Moreover, genes encoding the biosynthesis of
malleobactin and pyochelin were upregulated and increased
secretion of siderophores by treated B. pseudomallei was
observed. The authors suggest that the anti-infective effects
observed by curcumin are due to the bacteria diverting their
metabolism away from virulence and toward iron uptake to
ensure growth and maintenance. These observations provide
suggestive evidence for the importance of iron acquisition for
virulence in this organism.
BURKHOLDERIA GLADIOLI
B. gladioli was originally identified as a pathogen of Iridaceae,
specifically irises and gladioli, and then later was recognized as
the cause of infections in certain groups of immunocompromised
patients, particularly among those with CF and CGD (Boyanton
et al., 2005; Kennedy et al., 2007). The iron acquisition systems
of this organism have yet to be determined. However, the
genome sequence offers a few clues. We note that it does not
contain orthologs of the genes for the biosynthesis of ornibactin,
malleobactin, pyochelin, or cepaciachelin (Table 1). However, it
does contain orthologs of the bhuRSTUV genes. Unusually, these
genes are organized into two separate operons that are present on
chromosome 1 (bhuRST) and chromosome 2 (bhuUV) (results
not shown), but nevertheless suggest that B. gladioli may be able
to utilize haem as an iron source during infection of human hosts.
The B. gladioli genome also encodes a FtrABCD system. It is not
known whether one or both of these systems is important for
establishing an infection in humans.
CLOSING REMARKS
To conclude, we are still far from ascertaining the relative
importance of the different iron acquisition mechanisms
available to the Burkholderia that are brought to bear during
infection of a human host. A number of studies have been carried
out with B. cenocepacia to address this question which have
provided what might at first appear to be conflicting results.
However, as themodel systems are so varied, and the iron content
and/or availability in these systems is also markedly different,
we believe that most of these apparent contradictory results can
be rationalized. Nonetheless, in terms of whether high affinity
iron acquisition systems are essential for successful colonization
of the CF lung and which ones are deployed, further studies
are required. Due to the difficulty of working safely with B.
pseudomallei and B. mallei fewer studies have been conducted,
but it would appear that neither the known siderophores of
B. pseudomallei nor its haem uptake system are important for
systemic melioidosis. There is great scope for further work into
the role of iron acquisition in the virulence of this important
group of bacteria.
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